Data Foundry

Drug recalls 2023

rocuronium — Class II drug recall D-1076-2023

Terminated recall by Central Admixture Pharmacy Services Inc, reported 2023-08-09, distributed nationwide. Lack of assurance of sterility: Lack of validation data for sanitization cycles

Recall numberD-1076-2023
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmCentral Admixture Pharmacy Services Inc, San Diego, CA, United States
Recall initiated2023-07-17
Classified2023-08-03
Reported by FDA2023-08-09
Terminated2025-03-21
DistributedNationwide (US)
Quantity10,065 syringes
Reason classessterility
NDC71286-6010-01
Lot numbers17-270519, 17-270605, 17-270684, 17-270898, 17-271074, 17-271324, 17-271603, 17-271670, 17-272529, 17-272883, 17-273235, 17-273245, 17-273262, 17-273263, 17-273264, 17-273418, 17-273768, 17-273788, 17-274022
Expiration dates2023-07-16, 2023-07-17, 2023-07-18, 2023-07-20, 2023-07-24, 2023-07-27, 2023-08-01, 2023-08-02, 2023-08-17, 2023-08-23, 2023-08-30, 2023-09-03, 2023-09-07, 2023-09-12

Product

rocuronium, 50 mg /5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6010-1

Reason for recall

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1076-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.